Effector Therapeutics Inc (EFTR) — Cash Flow Reinvestment Rate
Effector Therapeutics Inc (EFTR) has a Cash Flow Reinvestment Rate of 0.00x as of June 2020, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $11.98 Million. Check Effector Therapeutics Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Effector Therapeutics Inc Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Effector Therapeutics Inc across 1 annual periods. Explore EFTR operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Effector Therapeutics Inc (2020–2020)
Year-by-year capital reinvestment analysis for Effector Therapeutics Inc. For live market cap and broader valuation context, see Effector Therapeutics Inc market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.02x | $308.00K | $13.84 Million | $154.00K | — |